Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells

Biochemical and Biophysical Research Communications

Volumn 374, Issue 1, 2008, Pages 84-89

  Kamemura, Kazuo ^a,b   Ito, Akihiro ^a   Shimazu, Tadahiro ^a   Matsuyama, Akihisa ^a,b   Maeda, Satoko ^a   Yao, Tso Pang ^c   Horinouchi, Sueharu ^d   Khochbin, Saadi ^e   Yoshida, Minoru ^a,b,d  

^a RIKEN   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e INSERM   (France)

Author keywords

A549 cells; Acetylation; EGFR; ERK; HDAC6; HSP90; Knockdown; Microtubule

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA TUBULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; TRANSFERRIN RECEPTOR;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG CANCER; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 47949121045     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.092     Document Type: Article

References (26)

1. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.-F., and Yao T.-P. HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002) 455-458
2. Matsuyama A., Shimazu T., Sumida Y., Saito A., Yoshimatsu Y., Seigneurin-Berny D., Osada H., Komatsu Y., Nishino N., Khochbin S., Horinouchi S., and Yoshida M. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 21 (2002) 6820-6831
3. Zhang Y., Li N., Caron C., Matthias G., Hess D., Khochbin S., and Matthias P. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22 (2003) 1168-1179
4. Schulze E., Asai D.J., Bulinski J.C., and Kirschner M. Posttranslational modification and microtubule stability. J. Cell Biol. 105 (1987) 2167-2177
5. Piperno G., LeDizet M., and Chang X.-J. Microtubules containing acetylated α-tubulin in mammalian cells in culture. J. Cell Biol. 104 (1987) 289-302
6. Westermann S., and Weber K. Post-translational modifications regulate microtubule function. Nat. Rev. Mol. Cell Biol. 4 (2003) 938-947
7. Saji S., Kawakami M., Hayashi S.-I., Yoshida N., Hirose M., Horiguchi S.-I., Itoh A., Funata N., Schreiber S.L., Yoshida M., and Toi M. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 24 (2005) 4531-4539
8. Reed N.A., Cai D., Blasius T.L., Jih G.T., Meyhofer E., Gaertig J., and Verhey K.J. Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol. 16 (2006) 2166-2172
9. Dompierre J.P., Godin J.D., Charrin B.C., Cordelières F.P., King S.J., Humbert S., and Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci. 27 (2007) 3571-3583
10. Kovacs J.J., Murphy P.J.M., Gaillard S., Zhao X., Wu J.-T., Nicchitta C.V., Yoshida M., Toft D.O., Pratt W.B., and Yao T.-P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 18 (2005) 601-607
11. Bali P., Pranpat M., Bradner J., Balasis M., Fiskus W., Guo F., Rocha K., Kumaraswamy S., Boyapalle S., Atadja P., Seto E., and Bhalla K. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis of antileukemia activity of histone deacetylase inhibitors. J. Biol. Chem. 280 (2005) 26729-26734
12. Matei D., Satpathy M., Cao L., Lai Y.-C., Nakshatri H., and Donner D.B. The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells. J. Biol. Chem. 282 (2007) 445-453
13. Park J.-H., Kim S.-H., Choi M.-C., Lee J., Oh D.-Y., Im S.-A., Bang Y.-J., and Kim T.-Y. Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun. 368 (2008) 318-322
14. Zhang Y., Kwon S.-H., Yamaguchi T., Cubizolles F., Rousseaux S., Kneissel M., Cao C., Li N., Cheng H.-L., Chua K., Lombard D., Mizeracki A., Matthias G., Alt F.W., Khochbin S., and Matthias P. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell. Biol. 28 (2008) 1688-1701
15. Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., and Yao T.-P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115 (2003) 727-738
16. Maxfield F.R., and McGraw T.E. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5 (2004) 121-132
17. Zhang P., Gao W.Y., Turner S., and Ducatman B.S. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Mol. Cancer 2 (2003) 1
18. Xu W., Mimnaugh E., Rosser M.F.N., Nicchitta C., Marcu M., Yarden Y., and Neckers L. Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Biol. Chem. 276 (2001) 3702-3708
19. Shimamura T., Lowell A.M., Engelman J.A., and Shapiro G.I. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res. 65 (2005) 6401-6408
20. Yang S., Qu S., Perez-Tores M., Sawai A., Rosen N., Solit D.B., and Arteaga C.L. Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Cancer Res. 66 (2006) 6990-6997
21. Tiseo M., Loprevite M., and Ardizzoni A. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer. Curr. Med. Chem. Anticancer Agents 4 (2004) 139-148
22. Harari P.M. Epidermal growth factor receptor inhibition strategies in oncology. Endocr. Relat. Cancer 11 (2004) 689-708
23. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
24. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
25. Yu C., Dasmahapatra G., Dent P., and Grant S. Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. Leukemia 19 (2005) 1579-1589
26. Yu C., Subler M., Rahmani M., Reese E., Krystal G., Conrad D., Dent P., and Grant S. Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways. Cancer Biol. Ther. 2 (2003) 544-551